Risk for re-revision and type of antibiotic-loaded bone cement in hip or knee arthroplasty revisions: report of the Dutch Arthroplasty Register

Authors

  • Pieter K Bos Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam
  • Anneke Spekenbrink-Spooren Dutch Arthroplasty Register (Landelijke Registratie Orthopedische Interventies), ’s-Hertogenbosch
  • Peter Croughs Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam
  • Sita M A Bierma-Zeinstra Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam; Department of General Practice, Erasmus MC University Center Rotterdam, Rotterdam, the Netherlands https://orcid.org/0000-0003-1280-5896
  • Max Reijman Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam https://orcid.org/0000-0001-6316-9629
  • Jakob van Oldenrijk Department of Orthopedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam

DOI:

https://doi.org/10.2340/17453674.2023.18645

Keywords:

Arthroplasty, Bone cement, Fractures, Infection, Survival analysis

Abstract

Background and purpose: High-dose dual antibiotic-loaded bone cement (ALBC) may reduce the risk of revision after total hip and knee replacements. The aim of our study therefore was to determine the risk of re-revision following first time aseptic hip or knee revision using single versus dual ALBC.
Patients and methods: Patients from the Dutch Arthroplasty Register treated from 2007 to 2018 with first time cemented aseptic hip (n = 2,529) or knee revisions (n = 7,124) were incorporated into 2 datasets. The primary endpoint of this observational cohort study was subsequent all-cause re-revision. Multivariable Cox proportional hazard and competing risk was analyzed for both groups.
Results: There was no difference in re-revision rate (any reason) with single versus dual ALBC (hazard ratio 1.06, 95% confidence interval [CI] 0.83–1.35 for hip and 0.93, CI 0.80–1.07 for knee revisions). The 10-year crude cumulative re-revision rate also showed no differences for single versus dual ALBC use. The crude cumulative 7-year THA re-revision and 9-year TKA re-revision rates did not show any difference in implant survival for common cement types used.
Conclusion: We could not confirm the potential benefit of using dual ALBC compared with single ALBC for aseptic hip and knee revisions.

Downloads

Download data is not yet available.

References

Sprowson A P, Jensen C, Chambers S, Parsons N R, Aradhyula N M, Carluke I, et al. The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip: the Fractured Hip Infection trial. Bone Joint J 2016; 98-B(11): 1534-41. doi: 10.1302/0301-620X.98B11.34693. DOI: https://doi.org/10.1302/0301-620X.98B11.34693

Abdelaziz H, von Forster G, Kuhn K D, Gehrke T, Citak M. Minimum 5 years’ follow-up after gentamicin- and clindamycin-loaded PMMA cement in total joint arthroplasty. J Med Microbiol 2019; 68(3): 475-9. doi: 10.1099/jmm.0.000895. DOI: https://doi.org/10.1099/jmm.0.000895

Sanz-Ruiz P, Matas-Diez J A, Villanueva-Martinez M, Santos-Vaquinha Blanco A D, Vaquero J. Is dual antibiotic-loaded bone cement more effective and cost-efficient than a single antibiotic-loaded bone cement to reduce the risk of prosthetic joint infection in aseptic revision knee arthroplasty? J Arthroplasty 2020; 35(12): 3724-9. doi: 10.1016/j.arth.2020.06.045. DOI: https://doi.org/10.1016/j.arth.2020.06.045

LROI. Data quality completeness. Annual report; 2020.

LROI. Dutch Arthroplasty Registry. Online LROI annual report; 2020.

van Steenbergen L N, Denissen G A, Spooren A, van Rooden S M, van Oosterhout F J, Morrenhof J W, et al. More than 95% completeness of reported procedures in the population-based Dutch Arthroplasty Register. Acta Orthop 2015; 86(4): 498-505. doi: 10.3109/17453674.2015.1028307. DOI: https://doi.org/10.3109/17453674.2015.1028307

von Elm E, Altman D G, Egger M, Pocock S J, Gotzsche P C, Vandenbroucke J P, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014; 12(12): 1495-9. doi: S1743-9191(14)00212-X [pii]10.1016/j.ijsu.2014.07.013. DOI: https://doi.org/10.1016/j.ijsu.2014.07.013

Lacny S, Wilson T, Clement F, Roberts D J, Faris P D, Ghali W A, et al. Kaplan–Meier survival analysis overestimates the risk of revision arthroplasty: a meta-analysis. Clin Orthop Relat Res 2015; 473(11): 3431-42. doi: 10.1007/s11999-015-4235-8 10.1007/s11999-015-4235-8 [pii]. DOI: https://doi.org/10.1007/s11999-015-4235-8

Hansen E N, Adeli B, Kenyon R, Parvizi J. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. J Arthroplasty 2014; 29(6): 1123-7. doi: 10.1016/j.arth.2013.12.004. DOI: https://doi.org/10.1016/j.arth.2013.12.004

Engesaeter L B, Lie S A, Espehaug B, Furnes O, Vollset S E, Havelin L I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74(6): 644-51. doi: 10.1080/00016470310018135. DOI: https://doi.org/10.1080/00016470310018135

Leta T H, Gjertsen J E, Dale H, Hallan G, Lygre S H L, Fenstad A M, et al. Antibiotic-loaded bone cement in prevention of periprosthetic joint infections in primary total knee arthroplasty: a register-based multicentre randomised controlled non-inferiority trial (ALBA trial). BMJ Open 2021; 11(1): e041096. doi: 10.1136/bmjopen-2020-041096. DOI: https://doi.org/10.1136/bmjopen-2020-041096

Farhan-Alanie M M, Burnand H G, Whitehouse M R. The effect of antibiotic-loaded bone cement on risk of revision following hip and knee arthroplasty. Bone Joint J 2021; 103-B(1): 7-15. doi: 10.1302/0301-620X.103B1.BJJ-2020-0391.R1. DOI: https://doi.org/10.1302/0301-620X.103B1.BJJ-2020-0391.R1

Bendich I, Zhang N, Barry J J, Ward D T, Whooley M A, Kuo A C. antibiotic-laden bone cement use and revision risk after primary total knee arthroplasty in U.S. veterans. J Bone Joint Surg Am 2020; 102(22): 1939-47. doi: 10.2106/JBJS.20.00102. DOI: https://doi.org/10.2106/JBJS.20.00102

Yayac M, Rondon A J, Tan T L, Levy H, Parvizi J, Courtney P M. The economics of antibiotic cement in total knee arthroplasty: added cost with no reduction in infection rates. J Arthroplasty 2019; 34(9): 2096-101. doi: 10.1016/j.arth.2019.04.043. DOI: https://doi.org/10.1016/j.arth.2019.04.043

Namba R S, Prentice H A, Paxton E W, Hinman A D, Kelly M P. Commercially prepared antibiotic-loaded bone cement and infection risk following cemented primary total knee arthroplasty. J Bone Joint Surg Am 2020; 102(22): 1930-8. doi: 10.2106/JBJS.19.01440. DOI: https://doi.org/10.2106/JBJS.19.01440

Tyas B, Marsh M, Oswald T, Refaie R, Molyneux C, Reed M. Antibiotic resistance profiles of deep surgical site infections in hip hemiarthroplasty: comparing low dose single antibiotic versus high dose dual antibiotic impregnated cement. J Bone Jt Infect 2018; 3(3): 123-9. doi: 10.7150/jbji.22192jbjiv03p0123 [pii]. DOI: https://doi.org/10.7150/jbji.22192

Monzon R A, Coury J G, Disse G D, Lum Z C. Bone cement in total hip and knee arthroplasty. JBJS Rev 2019; 7(12): e6. doi: 10.2106/JBJS.RVW.19.00031. DOI: https://doi.org/10.2106/JBJS.RVW.19.00031

Antimicrobial Resistance C. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399(10325): 629-55. doi: 10.1016/S0140-6736(21)02724-0. DOI: https://doi.org/10.1016/S0140-6736(21)02724-0

Published

2023-09-20

How to Cite

Bos, P. K., Spekenbrink-Spooren, A., Croughs, P., Bierma-Zeinstra, S. M. A., Reijman, M., & van Oldenrijk, J. (2023). Risk for re-revision and type of antibiotic-loaded bone cement in hip or knee arthroplasty revisions: report of the Dutch Arthroplasty Register. Acta Orthopaedica, 94, 471–476. https://doi.org/10.2340/17453674.2023.18645